What do we know about Omicron? the variant that is causing millions of infections
The Omicron variant that appeared in South Africa in November 2021 displaced the Delta variant in 3-4 weeks in over 100 countries and now represents 90%...
News about Covid-19
The Hospital Clínic has started to administer the third dose of the COVID-19 vaccine to its professionals
The aim is to vaccinate as many professionals as possible as quickly as possible.
8 out of 10 COVID-19 patients have long-term symptoms
Long COVID has already been defined as a disease by WHO. It usually appears three months after the onset of infection. Studies show that 80% of patients...
Nearly 250 students take part in the IDIBAPS science workshops for Science Week
On Tuesday 16 November and Wednesday 17 November, school-leaving students and students in higher education took part in the open-air science workshops...
AEMPS authorizes Phase IIb clinical trial of HIPRA Covid-19 vaccine
The biotechnological pharmaceutical company HIPRA has received authorization from the Spanish Agencyfor Medicines and Health Products (AEMPS) to start...
IDIBAPS organizes science workshops on COVID-19 for school-leaving students
On 16 and 17 November, as part of 2021 Science Week, IDIBAPS is organizing a new edition of Generació Ciència (Generation Science), outdoor science workshops...
The importance of annual flu vaccination for healthcare personnel
The COVID-19 pandemic has emphasised the importance of vaccination. Every year the public faces the influenza virus, which causes more than 200,000 deaths...
Determinants associated with a severe form of COVID-19 in people living with HIV in Catalonia identified
The results show that people with HIV with chronic comorbidities and an unsuppressed HIV viral load could be at greater risk of developing severe COVID-19...
One year after having COVID, loss of smell remains in 1 in 3 patients
Long COVID involves significant limitations in terms of quality of life, including among young people. One of the sequelae that has the greatest impact...
Low levels of antibodies for the S protein of SARS-CoV-2 are associated with a higher risk of death in critical COVID-19 patients
The study, led by CIBERES, included the participation of IDIBAPS and was published in the Journal of Internal Medicine.